Explain this page
Arphra AIPlain-English read on Repligen Corporation’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $163.14 (+33.38%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.35% | -0.22% | -2.74% | +1.93% | -25.86% | -25.36% | -4.67% | -27.51% | -33.47% | +387.10% | +987.20% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$122.00
151 sh
Bid
$116.56
1 sh
Ask
$128.99
2 sh
Spread
$12.430
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?zacks.com·Jun 04, 2026
- Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcriptseekingalpha.com·Jun 03, 2026
- Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conferenceglobenewswire.com·May 07, 2026
Peers
No peer list available for RGEN.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|